139 related articles for article (PubMed ID: 33794728)
21. Divergent trends of hospitalizations for upper and lower gastrointestinal bleeding based on population prescriptions of aspirin, proton pump inhibitors and Helicobacter pylori eradication therapy: Trends of upper and lower gastrointestinal bleeding.
Guo CG; Zhang F; Wu JT; Cheung KS; Li B; Law SYK; Leung WK
United European Gastroenterol J; 2021 Jun; 9(5):543-551. PubMed ID: 33956403
[TBL] [Abstract][Full Text] [Related]
22. Bleeding risk associated with 1 year of dual antiplatelet therapy after percutaneous coronary intervention: Insights from the Clopidogrel for the Reduction of Events During Observation (CREDO) trial.
Aronow HD; Steinhubl SR; Brennan DM; Berger PB; Topol EJ;
Am Heart J; 2009 Feb; 157(2):369-74. PubMed ID: 19185647
[TBL] [Abstract][Full Text] [Related]
23. Coronary angiography with or without percutaneous coronary intervention in patients with hemophilia-Systematic review.
Boehnel C; Rickli H; Graf L; Maeder MT
Catheter Cardiovasc Interv; 2018 Jul; 92(1):1-15. PubMed ID: 28895303
[TBL] [Abstract][Full Text] [Related]
24. Risk factors and management of gastrointestinal bleeding in patients with or without antiplatelet and anticoagulation therapy: a multicenter real-world prospective study.
Hao W; Liu A; Zhu H; Yu X; Chen G; Xu J
BMC Gastroenterol; 2024 May; 24(1):155. PubMed ID: 38714955
[TBL] [Abstract][Full Text] [Related]
25. Assessment of safety of performing percutaneous coronary intervention after a recent episode of gastrointestinal bleeding.
Karim S; Ador-Dionisio ST; Karim M; Karim M; Khan SS; Atreja A; Ellis S
Acute Card Care; 2016 Mar; 18(1):1-6. PubMed ID: 27786543
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of the efficacy and safety of dual antiplatelet therapy with or without warfarin in patients with a clinical indication for DAPT and chronic anticoagulation: A meta-analysis of observational studies.
Bavishi C; Koulova A; Bangalore S; Sawant A; Chatterjee S; Ather S; Valencia J; Sarafoff N; Rubboli A; Airaksinen JK; Lip GY; Tamis-Holland JE
Catheter Cardiovasc Interv; 2016 Jul; 88(1):E12-22. PubMed ID: 26354765
[TBL] [Abstract][Full Text] [Related]
27. Impact of Nutritional and Inflammation Status on Long-Term Bleeding in Patients Undergoing Percutaneous Coronary Intervention with an Oral Anticoagulant.
Yoshida R; Ishii H; Morishima I; Tanaka A; Morita Y; Takagi K; Yoshioka N; Hirayama K; Iwakawa N; Tashiro H; Kojima H; Mitsuda T; Hitora Y; Furusawa K; Tsuboi H; Murohara T
J Atheroscler Thromb; 2019 Aug; 26(8):728-737. PubMed ID: 30584221
[TBL] [Abstract][Full Text] [Related]
28. Dual versus triple antithrombotic therapy after percutaneous coronary intervention or acute coronary syndrome in patients with indication for anticoagulation: an updated meta-analysis.
Shin D; Mohanty BD; Lee ES
Coron Artery Dis; 2018 Dec; 29(8):670-680. PubMed ID: 30222595
[TBL] [Abstract][Full Text] [Related]
29. Performance of HAS-BLED, ORBIT, PRECISE-DAPT, and PARIS risk score for predicting long-term bleeding events in patients taking an oral anticoagulant undergoing percutaneous coronary intervention.
Yoshida R; Ishii H; Morishima I; Tanaka A; Morita Y; Takagi K; Yoshioka N; Hirayama K; Iwakawa N; Tashiro H; Kojima H; Mitsuda T; Hitora Y; Furusawa K; Tsuboi H; Murohara T
J Cardiol; 2019 Jun; 73(6):479-487. PubMed ID: 30598387
[TBL] [Abstract][Full Text] [Related]
30. Personalized antiplatelet therapy guided by a novel detection of platelet aggregation function in stable coronary artery disease patients undergoing percutaneous coronary intervention: a randomized controlled clinical trial.
Zheng YY; Wu TT; Yang Y; Hou XG; Gao Y; Chen Y; Yang YN; Li XM; Ma X; Ma YT; Xie X
Eur Heart J Cardiovasc Pharmacother; 2020 Jul; 6(4):211-221. PubMed ID: 31603191
[TBL] [Abstract][Full Text] [Related]
31. Characteristics and clinical outcomes of patients with acute gastrointestinal bleeding related to anticoagulant or antiplatelet therapy: a retrospective study.
Božić D; Vuković J; Mustapić I; Vrebalov Cindro P; Božić J; Kardum G; Puljiz Ž; Tadin Hadjina I; Tonkić A
Croat Med J; 2021 Oct; 62(5):488-494. PubMed ID: 34730889
[TBL] [Abstract][Full Text] [Related]
32. Time-Dependent Associations Between Actionable Bleeding, Coronary Thrombotic Events, and Mortality Following Percutaneous Coronary Intervention: Results From the PARIS Registry.
Baber U; Dangas G; Chandrasekhar J; Sartori S; Steg PG; Cohen DJ; Giustino G; Ariti C; Witzenbichler B; Henry TD; Kini AS; Krucoff MW; Gibson CM; Chieffo A; Moliterno DJ; Weisz G; Colombo A; Pocock S; Mehran R
JACC Cardiovasc Interv; 2016 Jul; 9(13):1349-57. PubMed ID: 27388822
[TBL] [Abstract][Full Text] [Related]
33. Duration of Triple Antithrombotic Therapy and Outcomes Among Patients Undergoing Percutaneous Coronary Intervention.
Koskinas KC; Räber L; Zanchin T; Pilgrim T; Stortecky S; Hunziker L; Blöchlinger S; Billinger M; Gartwyl F; Moro C; Moschovitis A; Jüni P; Heg D; Windecker S
JACC Cardiovasc Interv; 2016 Jul; 9(14):1473-83. PubMed ID: 27478115
[TBL] [Abstract][Full Text] [Related]
34. Risk of rebleeding, vascular events and death after gastrointestinal bleeding in anticoagulant and/or antiplatelet users.
Sostres C; Marcén B; Laredo V; Alfaro E; Ruiz L; Camo P; Carrera-Lasfuentes P; Lanas Á
Aliment Pharmacol Ther; 2019 Oct; 50(8):919-929. PubMed ID: 31486121
[TBL] [Abstract][Full Text] [Related]
35. Endoscopy findings in patients on dual antiplatelet therapy following percutaneous coronary intervention.
Galusko V; Protty M; Haboubi HN; Verhemel S; Bundhoo S; Yeoman AD
Postgrad Med J; 2022 Aug; 98(1162):591-597. PubMed ID: 33879553
[TBL] [Abstract][Full Text] [Related]
36. Randomized clinical trial: the impact of gastrointestinal risk factor screening and prophylactic proton pump inhibitor therapy in patients receiving dual antiplatelet therapy.
Jensen BES; Hansen JM; Larsen KS; Junker AB; Lassen JF; Jensen SE; Schaffalitzky de Muckadell OB
Eur J Gastroenterol Hepatol; 2017 Oct; 29(10):1118-1125. PubMed ID: 28678044
[TBL] [Abstract][Full Text] [Related]
37. New oral anticoagulants in addition to single or dual antiplatelet therapy after an acute coronary syndrome: a systematic review and meta-analysis.
Oldgren J; Wallentin L; Alexander JH; James S; Jönelid B; Steg G; Sundström J
Eur Heart J; 2013 Jun; 34(22):1670-80. PubMed ID: 23470494
[TBL] [Abstract][Full Text] [Related]
38. Predictors and Management of Antiplatelet-Related Bleeding Complications for Acute Coronary Syndrome in Chinese Elderly Patients.
Wan J; Wang P; Zhou P; Liu S; Wang D; Kan J; Hou J; Zuo L; Ma S; Yang Y
Cell Physiol Biochem; 2018; 50(3):1164-1177. PubMed ID: 30355936
[TBL] [Abstract][Full Text] [Related]
39. Relationship Between Platelet Reactivity and Ischemic and Bleeding Events After Percutaneous Coronary Intervention in East Asian Patients: 1-Year Results of the PENDULUM Registry.
Nakamura M; Kadota K; Takahashi A; Kanda J; Anzai H; Ishii Y; Shibata Y; Yasaka Y; Takamisawa I; Yamaguchi J; Takeda Y; Harada A; Motohashi T; Iijima R; Uemura S; Murakami Y;
J Am Heart Assoc; 2020 May; 9(10):e015439. PubMed ID: 32394794
[TBL] [Abstract][Full Text] [Related]
40. [Management of antithrombotic therapy in patients with bleeding after percutaneous coronary intervention].
Capranzano P; Francaviglia B; Capodanno D; Tamburino C
G Ital Cardiol (Rome); 2020 Feb; 21(2 Suppl 1):34S-41S. PubMed ID: 32134406
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
